| Authors: |
Peters S; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Electronic address: https://twitter.com/peters_solange., Meyer ML; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., André F; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Université Paris-Saclay, Villejuif, France., Argilés G; Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Azizi AA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Electronic address: https://twitter.com/Alex_Azizi_., Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK., Burgers S; Department of Thoracic Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Curigliano G; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: https://twitter.com/curijoey., Drago JZ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: https://twitter.com/joshdragomd., Fontana E; Drug Development Unit, Sarah Cannon Research Institute, London, UK., Garon EB; David Geffen School of Medicine, University of California, Los Angeles, USA., Klümper N; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn; Department of Urology, University Hospital Bonn (UKB), Bonn, Germany; Institute of Experimental Oncology, University Hospital Bonn (UKB), Bonn, Germany. Electronic address: https://twitter.com/niklas_kluemper., Le Bescond L; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France; Molecular Predictors and New Targets in Oncology, INSERM U981, Gustave Roussy, Villejuif, France; Centre for Visual Computing, CentraleSupélec, Inria, Université Paris-Saclay, Gif-Sur-Yvette, France., Lopez-Rios F; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Mountzios G; 4th Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece. Electronic address: https://twitter.com/g_mountzios., Passaro A; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: https://twitter.com/APassaroMD., Paz-Ares L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: https://twitter.com/lpazares., Pistilli B; Department of Medical Oncology, Gustave Roussy, Villejuif, France; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France. Electronic address: https://twitter.com/BarbaraPistill2., Powles T; Barts Cancer Institute, National Institute for Health Research Biomedical Research Centre, Queen Mary University of London, London, UK. Electronic address: https://twitter.com/etop_ibcsg., Reguart N; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. Electronic address: https://twitter.com/nreguart., Remon J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Schmelzle T; Novartis Biomedical Research, Basel, Switzerland., Skynner MJ; Bicycle Therapeutics Ltd, Cambridge, UK., Smit E; Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, The Netherlands., Smyth E; NIHR Biomedical Research Centre, Oxford, UK. Electronic address: https://twitter.com/lizzysmyth1., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Oncology, University College London Hospitals, London, UK., Van Cutsem E; Department of Digestive Oncology, University Hospital Gasthuisberg and University of Leuven (KUL), Leuven, Belgium., Loi S; Department of Cancer Research, Peter MacCallum Cancer Center, Melbourne, Australia; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia., Stahel RA; Coordinating Center, ETOP IBCSG Partners Foundation, Bern, Switzerland. Electronic address: rolf.stahel@etop.ibcsg.org. |
